Women in their 40s often notice a wave of small red dots appearing on the chest, torso, and arms years before their periods stop. These are cherry angiomas, and perimenopause is one of the most active windows for new ones to form. The reason is not simply "estrogen drops." It is the opposite: perimenopause is defined by estrogen that surges and spikes irregularly before it finally falls, and those spikes are a direct signal for new blood vessel growth. Understanding the transition years changes what you expect and what you can do about it.
For the underlying mechanism of how estrogen drives new vessel formation at any life stage, see the cherry angiomas and hormones pillar.
Key takeaways
Perimenopause is the most active window for new cherry angiomas. Estrogen spikes, not just the eventual decline, are the driver.
- Perimenopause (roughly ages 40 to 51, while cycles are still present but irregular) involves estrogen that fluctuates sharply, including surges above premenopausal baseline.
- Each estrogen spike upregulates VEGF, a protein that signals the body to build new capillaries. More spikes means more cherry angiomas, which is why they often appear before periods stop.
- Post-menopause, when estrogen settles at a stable low, the rate of new cherry angiomas typically slows. The ones already formed are permanent structures and do not reabsorb on their own.
- HRT and combined oral contraceptives re-introduce estrogen into circulation and can trigger new angiomas through the same mechanism.
- Cherry angiomas are benign. Any spot that bleeds without trauma, grows rapidly, or does not blanch under pressure warrants a dermatologist visit before any home treatment.
What cherry angiomas are (and why perimenopause makes them worse)
Cherry angiomas are small, benign domes of dilated blood vessels that sit just under the skin surface. Pressing one briefly makes it blanch, which distinguishes it from other types of spots. They are not dangerous and do not turn into anything serious. For what they look like across different skin tones and body locations, see the complete cherry angioma location and cause guide.
The reason perimenopause drives them is a biology point many sources get wrong. Perimenopause is not "estrogen declining." It is estrogen becoming unpredictable. Levels spike, drop, spike again, and only eventually fall for good. Each spike is a fresh angiogenic signal, the same mechanism that causes cherry angiomas during pregnancy. Women can enter this phase as early as the mid-30s and spend a decade in it before periods fully stop.
For the broader picture of how hormonal shifts at different life stages interact with skin conditions, see the hormonal skin changes hub.
The perimenopause estrogen pattern: spikes before the fall
How estrogen fluctuations trigger new vessel growth
Estrogen drives angiogenesis by upregulating vascular endothelial growth factor (VEGF), a protein that directs the body to build new capillaries. The relationship is dose-responsive: higher or more frequent estrogen signals mean more cherry angioma formation. During perimenopause, the pituitary gland keeps pushing harder to stimulate ovarian function, generating irregular estrogen surges. The American College of Obstetricians and Gynecologists describes the perimenopause transition as defined by these hormonal fluctuations, not a clean decline, which is why the skin response is often more pronounced in the transition years than after menopause proper.
This is what explains the timing so many women notice: cherry angiomas multiplying in their mid-40s, while cycles are still irregular but present, not after periods stop. The VEGF-angiogenesis signal is strongest during the high-variability window, not after estrogen stabilizes at its post-menopausal floor.
Anovulatory cycles and relative estrogen excess
One reason the perimenopausal years generate more cherry angiomas than post-menopause is anovulatory cycles. When a cycle occurs without ovulation, the normal rise-and-fall of estrogen and progesterone is disrupted. Progesterone, which usually counterbalances estrogen, stays low. The result is a state of relative estrogen excess even when total estrogen levels are not exceptionally high. For cherry angioma formation, what matters is the estrogen signal relative to the offsetting hormones. Perimenopause creates that imbalance repeatedly. The American Academy of Dermatology identifies estrogen as a key driver of cherry angioma formation, and the perimenopausal fluctuation pattern makes it an unusually active driver in the transition years.
Perimenopause vs. menopause: which phase are you in?
These two terms get used interchangeably, but they describe different biological phases with different skin implications. Knowing which one applies to you shapes what to expect.
| Phase | What is happening | Cherry angioma pattern |
|---|---|---|
| Perimenopause (approx. ages 40 to 51) | Irregular cycles. Estrogen fluctuates sharply. Spikes above baseline. Progesterone often low due to anovulatory cycles. You are still having periods, even if unpredictably. | Most active window for new formation. Repeated estrogen spikes generate repeated VEGF surges. This is the phase where many women first notice a significant increase in cherry angiomas. |
| Menopause (12 months after last period) | Ovarian estrogen production has largely stopped. Estrogen is now at a stable, lower level. The fluctuation phase is over. | Rate of new cherry angiomas typically slows. The ones formed during perimenopause do not reabsorb. |
| Post-menopause (ongoing) | Estrogen stays at its new stable low. Symptoms of the transition phase (hot flashes, sleep disruption) often ease over time. | Minimal new cherry angioma formation. Existing ones remain. Some women on HRT see renewed formation if the added estrogen restarts the angiogenic signal. |
If you are in the post-menopause phase and want the full picture on what that estrogen stabilization means for cherry angiomas, see the cherry angiomas and menopause article.
Why cherry angiomas appear before periods stop
Most women notice cherry angiomas for the first time, or in significantly larger numbers, between ages 40 and 50. That window maps almost exactly onto the perimenopause transition, years before the last period. The overlap is not coincidence.
Three things stack in that window. First, the estrogen fluctuation of perimenopause generates repeated VEGF surges, each one a signal to build new capillaries. Second, cumulative UV exposure across decades has weakened the microvasculature of the skin, making it more responsive to those signals. Third, age itself slows the normal regression of small vessels. The result is a period where cherry angiomas form faster than at any other life stage, and they start forming years before menopause is officially reached.
For the broader question of why a wave of new cherry angiomas can appear suddenly at midlife even without any obvious hormonal event, see why am I suddenly getting cherry angiomas. For the pregnancy comparison where a similar estrogen-surge mechanism plays out over a shorter window, see the cherry angiomas during pregnancy guide.
Established triggers, suspected ones, and what is not
Because many sources tie cherry angiomas to hormones in vague ways, here is the honest split for the perimenopause window specifically.
| Evidence level | What it covers | How to read it |
|---|---|---|
| Established | Age (35 plus). Estrogen fluctuation and spikes in perimenopause. Anovulatory cycles creating relative estrogen excess. Cumulative UV exposure. Genetic predisposition. HRT or combined oral contraceptives that raise circulating estrogen. | Consistent across dermatology and gynecology literature. You can rely on these as real drivers in the transition years. |
| Suspected, not proven | Liver estrogen clearance as a secondary amplifier during perimenopause. Stress-driven cortisol-estrogen interplay accelerating the perimenopausal transition and its skin effects. | Mechanistically plausible. Not yet isolated in controlled studies. Reasonable to expect some effect but not guaranteed. |
| Not established | Diet-driven estrogen changes reversing existing cherry angiomas. "Hormone-balancing" supplements shrinking them. Phytoestrogens accelerating formation. Stress alone or sleep alone as a direct cause. | Case-report or marketing-claim level. Not worth being convinced about. The vessels that have formed are structural. |
The key reframe for perimenopause: it is not the declining average estrogen that drives cherry angioma formation. It is the peaks. Estrogen on its way down, with spikes above baseline, is still a meaningful angiogenic stimulus.
HRT and birth control during perimenopause
Some women start HRT in perimenopause to manage symptoms like hot flashes and sleep disruption. Combined oral contraceptives are also used during perimenopause to regulate irregular cycles. Both add estrogen to a system that is already generating angiogenic signals. The result is that women who start hormonal treatment during perimenopause sometimes report a surge of new cherry angiomas in the months after starting.
This is a predictable biological response, not a sign the treatment is wrong. Stopping HRT will not reverse cherry angiomas already formed. It may slow the pace of new ones over time, but the underlying perimenopausal fluctuation is still present while cycles continue. Medication decisions go through your doctor. The NIH MedlinePlus skin conditions resource confirms cherry angiomas are benign and do not resolve without treatment.
In perimenopause, cherry angiomas form from estrogen spikes, not just the eventual decline. The ones that form are permanent. Removal is the direct path to clear skin.
The bottom line
Cherry angiomas multiply in perimenopause because the transition years are defined by estrogen that spikes irregularly, not a clean decline. Each spike is a VEGF-driven signal for new capillary formation. Most women notice the highest rate of new cherry angiomas in their 40s, before periods stop, because that is when estrogen variability peaks. Post-menopause, when estrogen settles at a stable low, the rate of new formation typically slows. The ones already formed are permanent structures in the dermis.
The practical plan: understand the transition-specific driver, monitor any spot that changes, and remove the ones you want gone. At-home removal with a focused plasma device takes about five minutes per spot. A scab forms and falls off by day 3 to 7, and the skin renews to clear by week 2 to 3.
If anything looks unusual (bleeding, rapid growth, no blanching, asymmetric border), see a dermatologist before treating it yourself. The Mayo Clinic guidance on benign skin lesions is a useful general reference for when a spot warrants professional evaluation.
28,000+
Customers served
90 days
Risk-free trial
At home
No clinic, no appointment
FAQ
Frequently asked questions
Real questions women in perimenopause ask about cherry angiomas and the early estrogen shift.
↓ Tap each question to reveal the answer.
Clear skin, on your own terms
The OcuraLife Plasma Pen is built for this
Delivers focused plasma energy at the spot. 9 adjustable power settings, single-use tips. A scab forms and falls off on its own, and the skin renews by week 2 to 3.
See the Plasma PenWorks alongside: Numbing Cream | Healing Patches | SPF 50 Sunscreen
